Benchmark Upgrades Exact Sciences to Buy, Announces $91 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson upgraded Exact Sciences (NASDAQ:EXAS) from Hold to Buy and set a price target of $91.

January 02, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences was upgraded by Benchmark analyst Bruce Jackson from Hold to Buy with a new price target of $91.
Analyst upgrades typically lead to positive short-term price movement as they suggest improved fundamentals or future prospects. The new price target of $91 implies a significant upside from the current trading level, which can attract investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100